Success Stories: With Our Meticulous Efforts, A Research Postdoctoral Fellow from Jordan Working in the Field of Nanomedicine Achieved NIW Approval

Posted by wegreened on May 22, 2024 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

“Excellent service. High professionalism, great attention to detail, and clear guidance throughout the process.Thank you. It has been a pleasure working with you. I would definitely recommend it to others.”

On May 13^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Research Postdoctoral Fellow in the Field of Nanomedicine (Approval Notice).

General Field: Nanomedicine

Position at the Time of Case Filing: Research Postdoctoral Fellow

Country of Origin: Jordan

State of Residence at the Time of Filing: Maryland

Approval Notice Date: May 13^th, 2023

Processing Time: 3 months

Case Summary:

One of the few leading experts to improve the delivery of mRNA therapeutics to increase the effectiveness of gene therapies for incurable conditions, our client achieved a consistent and remarkable record of success and influence in these areas of study. He approached the North America Immigration Law Group to help him build an influential I-140 NIW (National Interest Waiver) petition, establishing that he is well-known for:

Formulating and characterizing novel nanoparticles, conducting in vivo imaging, developing advanced animal models to test his therapeutics, and publishing original nanomedicine research in peer-reviewed journals and conference proceedings.
His lipid-based encapsulation of anti-cancer drugs limits the side effects of chemotherapy, which enhances the safety and health outcomes of cancer patients worldwide.

His splendid credentials ensured that we countersigned the client-attorney relationship agreement and proceeded with preparing a strong petition dossier to achieve the national interest waiver for our noteworthy client. We highlighted the following important aspects while filing his NIW case:

Peer-review experience is considered to be a widely accepted method for research validation with publishers relying on the peer-review process to uphold the quality and validity of individual articles and the journals that publish them. Therefore, he evaluated the work of his peers no fewer than 26 times.
His research has resulted in 9 peer-reviewed journal articles (6 of them first-authored) and 2 published patents, published in the top journals of his field, reflecting his peers’ recognition of the value of this research.
His publications attracted 110 citations from a wide audience hailing from well-known international institutions both in the United States and abroad.

Not only did we assist him in devising this successful case but also made sure to compile all the new information provided by our client to be incorporated in his petition to meet the requirements.

Moreover, his work was funded by:

the Japan Science and Technology Agency, the Japan Agency for Medical Research and Development, and the Japan Society for the Promotion of Science. This funding supports projects that commercialize new technologies, provide foundations of social development, and lengthen the lives of people worldwide.

Therefore, our client’s research addresses these goals by developing novel nanomedicine delivery systems to improve the efficacy of existing gene editing tools and improving vital therapeutics for brain diseases that shorten lives, such as Alzheimer’s.

Furthermore, he even got 4 recommendation letters in his favor, one excerpt out of the same is mentioned below:

“[Client's] novel lipid pharmaceutical excipient is a substantial discovery for the pharmaceutical industry as it promises improved absorption of drugs which would allow for dose reduction of active ingredients…This presents a massive benefit to the American public and allows for cheaper and more accessible treatments.”

Overall, we are glad that we were able to prove to the USCIS that our client’s research would be beneficial for the entire nation as his proposed endeavor of improving the delivery of mRNA therapeutics to increase the effectiveness of gene therapies for incurable conditions directly addresses critical issues related to high prescription drug costs, the sustainability of the biopharmaceutical industry in the U.S., vaccine efficacy, and reducing undesirable drug side-effects from anti-cancer drugs. Thus he received his NIW approval despite a long wait.

We truly thank him for his constant cooperation and kind support throughout the adjudication process and wish him good luck in his upcoming endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%